Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Epidemiology and pathogenesis of West Nile virus infection

Lyle R Petersen, MD, MPH
Section Editor
Martin S Hirsch, MD
Deputy Editor
Jennifer Mitty, MD, MPH


West Nile (WN) virus, a member of the Japanese encephalitis virus antigenic complex, was first isolated in a blood sample in a patient from the West Nile province of Uganda in 1937 [1]. This RNA virus was initially considered of minor public health importance [2]. It emerged from obscurity in 1999 when the first incursion of the virus into North America caused 62 cases of encephalitis and seven deaths in New York [3]. Since that time, the virus has dramatically spread, and WN virus activity has now been detected in all 48 continental states, the District of Columbia, and Puerto Rico [4]. WN virus causes both sporadic infection and outbreaks that may be associated with severe neurologic disease.

The epidemiology and pathogenesis of West Nile virus will be addressed here. The clinical manifestations, diagnosis and treatment of infection are discussed elsewhere. (See "Clinical manifestations and diagnosis of West Nile virus infection" and "Treatment and prevention of West Nile virus infection".)


West Nile (WN) virus is one of the most widely distributed of all arboviruses with an extensive distribution in the Old World, throughout Africa, the Middle East, parts of Europe and the former Soviet Union, South Asia, and Australia [2]. The virus had not been detected in the Americas before the 1999 New York City outbreak. It is unknown how WN virus got to the United States. While initial phylogenetic studies suggested a Middle Eastern origin for the North American WN virus [5,6], subsequent analysis indicated that WN strains now circulating in Europe and Israel originated from the same independent location, probably North Africa [7]. WN virus is now considered endemic in North America [8].

Patterns of illness — Since the first discovery of WN virus, infrequent human outbreaks were mostly reported in groups of soldiers, children, and healthy adults in Israel and Africa [9-12]. These outbreaks were associated with only minor illness in the majority of patients; some case fatalities were associated with increasing age. In one of the largest outbreaks reported, thousands of self-limited and relatively mild clinical cases, consisting of fever, rash, and polyarthralgias occurred in South Africa, resulting in an epidemic attack rate of 55 percent [13].

However, since the mid-1990s, outbreaks of WN virus infection associated with severe neurologic disease began to occur in North Africa (Algeria [1994, 1997], Tunisia [1997], Sudan [2002]); Europe (Romania [1996]); Russia (1999); Israel (2000); North America (United States [1999], Canada [2002]); and India (2011) [4,14-19]. In each of these outbreaks, the mortality among patients with meningitis and encephalitis was approximately 10 percent, and occurred more often in elderly patients. Since 2002, outbreaks have also occurred in multiple southern European countries, with annual epidemic cycles in some countries related to the spread of WN virus lineage 2 strains [20,21].

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Sep 2017. | This topic last updated: Sep 07, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Smithburn K, Hughes T, Burke A, et al. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940; 20:471.
  2. Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007; 45:1039.
  3. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807.
  4. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA 2013; 310:308.
  5. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286:2333.
  6. Giladi M, Metzkor-Cotter E, Martin DA, et al. West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis 2001; 7:659.
  7. May FJ, Davis CT, Tesh RB, Barrett AD. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol 2011; 85:2964.
  8. Brown CM, DeMaria A Jr. The resurgence of West Nile virus. Ann Intern Med 2012; 157:823.
  9. Petersen LR, Roehrig JT. West Nile virus: a reemerging global pathogen. Emerg Infect Dis 2001; 7:611.
  10. Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004; 23:147.
  11. Murgue B, Murri S, Triki H, et al. West Nile in the Mediterranean basin: 1950-2000. Ann N Y Acad Sci 2001; 951:117.
  12. Jupp PG. The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans. Ann N Y Acad Sci 2001; 951:143.
  13. McIntosh BM, Jupp PG, Dos Santos I, et al. Epidemics of West Nile and Sindbis viruses in South Africa with Culex (Culex) univittatus Theobold as vector. S Afr J Sci 1970; 72:295.
  14. Tsai TF, Popovici F, Cernescu C, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352:767.
  15. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7:675.
  16. Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 2001; 7:128.
  17. Drebot MA, Lindsay R, Barker IK, et al. West Nile virus surveillance and diagnostics: A Canadian perspective. Can J Infect Dis 2003; 14:105.
  18. Danis K, Papa A, Papanikolaou E, et al. Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011. Euro Surveill 2011; 16.
  19. Anukumar B, Sapkal GN, Tandale BV, et al. West Nile encephalitis outbreak in Kerala, India, 2011. J Clin Virol 2014; 61:152.
  20. Rizzo C, Napoli C, Venturi G, et al. West Nile virus transmission: results from the integrated surveillance system in Italy, 2008 to 2015. Euro Surveill 2016; 21.
  21. Rizzoli A, Jimenez-Clavero MA, Barzon L, et al. The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill 2015; 20.
  22. Krow-Lucal E, Lindsey NP, Lehman J, et al. West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2015. MMWR Morb Mortal Wkly Rep 2017; 66:51.
  23. Hahn MB, Monaghan AJ, Hayden MH, et al. Meteorological conditions associated with increased incidence of West Nile virus disease in the United States, 2004-2012. Am J Trop Med Hyg 2015; 92:1013.
  24. Shand L, Brown WM, Chaves LF, et al. Predicting West Nile Virus Infection Risk From the Synergistic Effects of Rainfall and Temperature. J Med Entomol 2016; 53:935.
  25. Petersen LR, Hayes EB. West Nile virus in the Americas. Med Clin North Am 2008; 92:1307.
  26. Centers for Disease Control and Prevention. West Nile virus disease cases and deaths reported to CDC by year and clinical presentation, 1995-2015. https://www.cdc.gov/westnile/resources/pdfs/data/1-wnv-disease-cases-by-year_1999-2015_07072016.pdf (Accessed on August 28, 2017).
  27. Centers for Disease Control and Prevention (CDC). West Nile virus and other arboviral diseases--United States, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:513.
  28. Chung WM, Buseman CM, Joyner SN, et al. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 2013; 310:297.
  29. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358:261.
  30. Centers for Disease Control and Prevention (CDC). Serosurveys for West Nile virus infection--New York and Connecticut counties, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:37.
  31. Busch MP, Wright DJ, Custer B, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 2006; 12:395.
  32. Williamson PC, Custer B, Biggerstaff BJ, et al. Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic. Epidemiol Infect 2017; 145:2536.
  33. Schellenberg TL, Anderson ME, Drebot MA, et al. Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health 2006; 97:369.
  34. Government of Canada. Surveillance of West Nile virus. https://www.canada.ca/en/public-health/services/diseases/west-nile-virus/surveillance-west-nile-virus.html (Accessed on September 06, 2017).
  35. Centers for Disease Control and Prevention (CDC). West Nile Virus activity--United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:497.
  36. Cruz L, Cardenas VM, Abarca M, et al. Short report: serological evidence of West Nile virus activity in El Salvador. Am J Trop Med Hyg 2005; 72:612.
  37. Mattar S, Edwards E, Laguado J, et al. West Nile virus antibodies in Colombian horses. Emerg Infect Dis 2005; 11:1497.
  38. Adrián Diaz L, Komar N, Visintin A, et al. West Nile virus in birds, Argentina. Emerg Infect Dis 2008; 14:689.
  39. Morales MA, Barrandeguy M, Fabbri C, et al. West Nile virus isolation from equines in Argentina, 2006. Emerg Infect Dis 2006; 12:1559.
  40. Estrada-Franco JG, Navarro-Lopez R, Beasley DW, et al. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis 2003; 9:1604.
  41. Pupo M, Guzmán MG, Fernández R, et al. West Nile Virus infection in humans and horses, Cuba. Emerg Infect Dis 2006; 12:1022.
  42. Beatty ME, Hunsperger E, Long E, et al. Mosquitoborne infections after Hurricane Jeanne, Haiti, 2004. Emerg Infect Dis 2007; 13:308.
  43. Hunsperger EA, McElroy KL, Bessoff K, et al. West Nile virus from blood donors, vertebrates, and mosquitoes, Puerto Rico, 2007. Emerg Infect Dis 2009; 15:1298.
  44. Elizondo-Quiroga D, Davis CT, Fernandez-Salas I, et al. West Nile Virus isolation in human and mosquitoes, Mexico. Emerg Infect Dis 2005; 11:1449.
  45. Vieira MA, Romano AP, Borba AS, et al. West Nile Virus Encephalitis: The First Human Case Recorded in Brazil. Am J Trop Med Hyg 2015; 93:377.
  46. Bunning ML, Bowen RA, Cropp CB, et al. Experimental infection of horses with West Nile virus. Emerg Infect Dis 2002; 8:380.
  47. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353:460.
  48. Centers for Disease Control and Prevention (CDC). Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:877.
  49. Centers for Disease Control and Prevention (CDC). Laboratory-acquired West Nile virus infections--United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1133.
  50. Fonseca K, Prince GD, Bratvold J, et al. West Nile virus infection and conjunctival exposure. Emerg Infect Dis 2005; 11:1648.
  51. Centers for Disease Control and Prevention (CDC). Possible dialysis-related west nile virus transmission--Georgia, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:738.
  52. Turell MJ, Sardelis MR, Dohm DJ, O'Guinn ML. Potential North American vectors of West Nile virus. Ann N Y Acad Sci 2001; 951:317.
  53. Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 2003; 9:311.
  54. Komar O, Robbins MB, Klenk K, et al. West Nile virus transmission in resident birds, Dominican Republic. Emerg Infect Dis 2003; 9:1299.
  55. Swayne DE, Beck JR, Smith CS, et al. Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerg Infect Dis 2001; 7:751.
  56. LaDeau SL, Kilpatrick AM, Marra PP. West Nile virus emergence and large-scale declines of North American bird populations. Nature 2007; 447:710.
  57. George TL, Harrigan RJ, LaManna JA, et al. Persistent impacts of West Nile virus on North American bird populations. Proc Natl Acad Sci U S A 2015; 112:14290.
  58. Brault AC, Huang CY, Langevin SA, et al. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet 2007; 39:1162.
  59. Dietrich EA, Langevin SA, Huang CY, et al. West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms. PLoS Negl Trop Dis 2016; 10:e0004938.
  60. Watson JT, Jones RC, Gibbs K, Paul W. Dead crow reports and location of human West Nile virus cases, Chicago, 2002. Emerg Infect Dis 2004; 10:938.
  61. Johnson GD, Eidson M, Schmit K, et al. Geographic prediction of human onset of West Nile virus using dead crow clusters: an evaluation of year 2002 data in New York State. Am J Epidemiol 2006; 163:171.
  62. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236.
  63. Petersen LR, Epstein JS. Problem solved? West Nile virus and transfusion safety. N Engl J Med 2005; 353:516.
  64. Dodd RY, Foster GA, Stramer SL. Keeping Blood Transfusion Safe From West Nile Virus: American Red Cross Experience, 2003 to 2012. Transfus Med Rev 2015; 29:153.
  65. Centers for Disease Control and Prevention (CDC). West Nile virus transmission through blood transfusion--South Dakota, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:76.
  66. Centers for Disease Control and Prevention (CDC). Fatal West Nile virus infection after probable transfusion-associated transmission--Colorado, 2012. MMWR Morb Mortal Wkly Rep 2013; 62:622.
  67. Groves JA, Shafi H, Nomura JH, et al. A probable case of West Nile virus transfusion transmission. Transfusion 2017; 57:850.
  68. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196.
  69. Centers for Disease Control and Prevention (CDC). West Nile virus infections in organ transplant recipients--New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1021.
  70. Nett RJ, Kuehnert MJ, Ison MG, et al. Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis 2012; 14:268.
  71. Winston DJ, Vikram HR, Rabe IB, et al. Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features. Transplantation 2014; 97:881.
  72. Yango AF, Fischbach BV, Levy M, et al. West Nile virus infection in kidney and pancreas transplant recipients in the Dallas-Fort Worth Metroplex during the 2012 Texas epidemic. Transplantation 2014; 97:953.
  73. Inojosa WO, Scotton PG, Fuser R, et al. West Nile virus transmission through organ transplantation in north-eastern Italy: a case report and implications for pre-procurement screening. Infection 2012; 40:557.
  74. O'Leary DR, Kuhn S, Kniss KL, et al. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006; 117:e537.
  75. Nguyen Q, Teran S, Snedeker J, et al. CNS sequelae in an infant with congenital West Nile virus infection. Infect Med 2005; 22:626.
  76. Paisley JE, Hinckley AF, O'Leary DR, et al. West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics 2006; 117:814.
  77. Suthar MS, Diamond MS, Gale M Jr. West Nile virus infection and immunity. Nat Rev Microbiol 2013; 11:115.
  78. Gea-Banacloche J, Johnson RT, Bagic A, et al. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 2004; 140:545.
  79. Samuel MA, Diamond MS. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 2006; 80:9349.
  80. Samuel MA, Wang H, Siddharthan V, et al. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A 2007; 104:17140.
  81. Winkelmann ER, Luo H, Wang T. West Nile Virus Infection in the Central Nervous System. F1000Res 2016; 5.
  82. Diamond MS, Shrestha B, Marri A, et al. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003; 77:2578.
  83. Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 2003; 188:1.
  84. Lazear HM, Diamond MS. New insights into innate immune restriction of West Nile virus infection. Curr Opin Virol 2015; 11:1.
  85. Daniels BP, Holman DW, Cruz-Orengo L, et al. Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio 2014; 5:e01476.
  86. Tobler LH, Cameron MJ, Lanteri MC, et al. Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J Infect Dis 2008; 198:979.
  87. Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 2005; 79:13350.
  88. Shrestha B, Wang T, Samuel MA, et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 2006; 80:5338.
  89. Chung KM, Liszewski MK, Nybakken G, et al. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A 2006; 103:19111.
  90. Guarner J, Shieh WJ, Hunter S, et al. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 2004; 35:983.